Further, we have also observed that the adaptor molecule Grb2 interacts with both HER3 and MUC4 in pancreatic cancer cells, which suggests that HER3/MUC4 association leads to recruitment of Grb2 for HER3/MUC4 mediated downstream signaling pathway. Here, GRB2 is linked to pancreatic neoplasm.